Add BrightSurf on Google Email

BRCA mutations do not increase risk of colorectal cancer

A recent study found no association between BRCA mutations and an increased risk of colorectal cancer. Researchers tested blood samples from 1,422 patients with colorectal cancer and 1,566 control subjects for mutations in BRCA1 or BRCA2 genes. The results suggest that BRCA mutation carriers do not need to worry about an elevated risk ...

SourceMichigan Medicine - University of Michigan·JournalJNCI Journal of the National Cancer Institute·DateJan 6, 2004

Risk factors determine need for colonoscopy

Researchers developed a risk index to identify people at higher risk of finding advanced precancerous growths in the upper colon. The study found that older age, being male, and having certain types and sizes of polyps in the lower colon were associated with an increased probability of finding these growths.

SourceIndiana University·JournalAnnals of Internal Medicine·DateDec 15, 2003

New project will develop cancer maps for Pennsylvania

The Penn State project aims to create interactive maps of cancer rates in specific geographic areas, enabling better planning and evaluation of cancer interventions. Based on prostate and colorectal cancers, the model can be expanded to other states, utilizing available screenings and interventions to reduce cancer burden.

Other highlights of the June 4 JNCI

A study of over 78,000 women found that those who worked rotating night shifts for years had a 35% greater risk of developing colorectal cancer. Additionally, research on melanoma suggests two separate pathways may lead to its development, and polymorphisms in certain genes may be associated with prostate cancer risk.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJun 3, 2003

Success of chemotherapy tied to genetics

Researchers at McGill University discovered a genetic mutation, MTHFR variant, that predicts better response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer patients. The study found 26 out of 43 patients with the variant responded well to chemotherapy.

SourceMcGill University·JournalClinical Cancer Research·DateMay 7, 2003

Jefferson scientists find calcium is key to slowing colorectal cancer growth

Scientists at Thomas Jefferson University found that a bacterial toxin opens a cellular door, allowing calcium to flow into tumor cells, which slows cell division and may lead to new methods of treating colorectal cancer. The discovery could also enable the use of the toxin as an intravenous infusion to treat metastatic tumors.

SourceThomas Jefferson University·JournalProceedings of the National Academy of Sciences·DateFeb 10, 2003

Drug that cuts off a tumor’s blood supply shows promising results when paired with chemotherapy

Researchers have discovered that combining Avastin with chemotherapy provides superior treatment for advanced colorectal cancer, increasing median survival by 8.3 months and response rates. The study's findings suggest a more effective and less toxic option for patients with this devastating form of cancer.

SourceUniversity of California - Los Angeles·JournalJournal of Clinical Oncology·DateDec 28, 2002

High-than-average fiber consumption does not affect results of wheat bran fiber trial

A recent study published in the Journal of the National Cancer Institute found that a high-fiber diet did not affect the recurrence rate of adenomatous polyps in participants. The researchers separated the participants into four groups based on their baseline fiber consumption and calculated the risk of polyp recurrence in each group.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateNov 5, 2002

Annals of Internal Medicine, tip sheet, July 16, 2002

The US Preventive Services Task Force recommends that all adults over 50 be screened for colorectal cancer using methods like the fecal occult blood test or flexible sigmoidoscopy. The Task Force also notes that clot-busting drugs and angioplasty are underused in certain patient groups, particularly women and specific types of heart at...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateJul 15, 2002

Support for colorectal cancer screening

A UK trial suggests that flexible sigmoidoscopy is a suitable tool for population screening of colorectal cancer, with high attendance rates and low perforation risks compared to colonoscopy. The study's findings highlight the need for tailored approaches to screening, taking into account individual risk factors and efficiency.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 11, 2002